SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-17-005846
Filing Date
2017-06-19
Accepted
2017-06-19 16:06:28
Documents
4
Period of Report
2017-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp77409_8k.htm 8-K 19668
2 EXHIBIT 99.1 dp77409_ex9901.htm EX-99.1 10707
3 GRAPHIC logo.jpg GRAPHIC 18388
4 GRAPHIC logo01.jpg GRAPHIC 6714
  Complete submission text file 0000950103-17-005846.txt   66667
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 17918583
SIC: 2834 Pharmaceutical Preparations